BMRN FY 2010 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena

BMRNBioMarin Pharmaceutical Inc.

$11B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$376M+15.9% YoY

Gross Profit

$306M81.3% margin

Operating Income

$544,0000.1% margin

Net Income

$206M54.7% margin

EPS (Diluted)

$1.73

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

-$31M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$545M

Stockholders' Equity

$717M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$376M	$325M	+15.9%
Gross Profit	$306M	$259M	+18.3%
Operating Income	$544,000	$16M	-96.7%
Net Income	$206M	-$488,000	+42276.0%